Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153 | 80 | 180 | 94 | 65 |
| TOTAL | $239 | $231 | $381 | $123 | $101 |
| Non-Current Assets | |||||
| PPE Net | 39 | 39 | 39 | 0 | N/A |
| Other Non-Current Assets | 16 | 16 | 16 | 16 | 2 |
| TOTAL | $55 | $55 | $55 | $16 | $2 |
| Total Assets | $294 | $286 | $436 | $139 | $103 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,362 | 9,658 | 10,115 | 9,412 | 9,577 |
| Accrued Expenses | 3,823 | 3,439 | 3,446 | 3,192 | 3,203 |
| Other current liabilities | 839 | N/A | N/A | N/A | N/A |
| TOTAL | $26,124 | $19,801 | $19,944 | $19,978 | $19,430 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,854 | 3,422 | 1,643 | 1,274 | 1,359 |
| TOTAL | $1,854 | $3,422 | $1,643 | $1,274 | $1,359 |
| Total Liabilities | $27,978 | $23,223 | $21,587 | $21,252 | $20,789 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,199 | 4,495 | 4,393 | 3,998 | 3,898 |
| Common Shares | 73 | 72 | 70 | 62 | 58 |
| Retained earnings | -218,948 | -208,111 | -204,469 | -195,742 | -191,580 |
| Other shareholders' equity | -153 | -118 | -10 | -26 | -49 |
| TOTAL | $-27,684 | $-22,937 | $-21,151 | $-21,113 | $-20,686 |
| Total Liabilities And Equity | $294 | $286 | $436 | $139 | $103 |